Lgals9缺陷在降植烷诱导的BALB/c小鼠狼疮模型中减轻肾炎和关节炎的作用
该研究在降植烷诱导的BALB/c小鼠狼疮模型中,比较Gal-9+/+与Gal-9-/-雌鼠的关节炎、蛋白尿和自身抗体水平,并在注射后7个月评估肾脏病理、关节炎症和脂肪肉芽肿形成。结果显示Lgals9缺陷可减轻免疫复合物肾小球肾炎、关节炎和腹膜脂肪肉芽肿,且不改变脾和腹膜T细胞亚群、B细胞及Toll样受体7-I型干扰素通路。作者认为Gal-9是该模型狼疮肾炎和关节炎诱导与发生所必需,拮抗Gal-9可能通过靶向活化巨噬细胞使SLE患者获益。
要点
- Lgals9缺陷减轻降植烷诱导BALB/c小鼠的免疫复合物肾小球肾炎、关节炎和腹膜脂肪肉芽肿。
- Lgals9缺陷不改变降植烷注射小鼠脾和腹膜的T细胞亚群及B细胞群体。
- Lgals9缺陷在不改变Toll样受体7-I型干扰素通路的情况下减轻狼疮表现。
核心结论
- Gal-9是该小鼠SLE模型中狼疮肾炎和关节炎诱导与发生所必需的。
- 作者认为拮抗Gal-9可能通过靶向活化巨噬细胞成为治疗SLE患者肾炎和关节炎的潜在新策略。
研究设计与样本
- 研究将Gal-9+/+与Gal-9-/-雌性BALB/c小鼠注射降植烷,在注射后多个时间点评估关节炎严重程度、蛋白尿和自身抗体产生水平。
- 注射后7个月评估肾脏病理特征、关节炎症严重程度和脂肪肉芽肿形成,并分析脾和腹腔灌洗液中炎症细胞亚群及腹膜巨噬细胞细胞因子表达水平。
主要发现
- Lgals9缺陷保护BALB/c小鼠免于降植烷诱导狼疮模型中的免疫复合物肾小球肾炎、关节炎和腹膜脂肪肉芽肿形成。
- Lgals9缺陷未改变降植烷注射BALB/c小鼠脾和腹膜中T细胞亚群及B细胞群体。
- Lgals9缺陷在不改变Toll样受体7-I型干扰素通路的情况下保护小鼠免于降植烷诱导狼疮。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: In systemic lupus erythematosus (SLE), an autoimmune disease associated with multiple organ involvement, the development of lupus nephritis determines prognosis, and arthritis impairs quality of life. Galectin 9 (Gal-9, Lgals9) is a β-galactoside-binding lectin that has been used for clinical application in autoimmune diseases, since recombinant Gal-9, as a ligand for T cell immunoglobulin and mucin domain-containing protein 3 (TIM-3), induces apoptosis of activated CD4+TIM-3+ Th1 cells. This study was undertaken to investigate whether deficiency of Lgals9 has beneficial or deleterious effects on lupus in a murine model. METHODS: Gal-9+/+ and Gal-9-/- female BALB/c mice were injected with pristane, and the severity of arthritis, proteinuria, and levels of autoantibody production were assessed at several time points immediately following injection. At 7 months after pristane injection, renal pathologic features, the severity of joint inflammation, and formation of lipogranulomas were evaluated. Subsets of inflammatory cells in the spleen and peritoneal lavage were characterized, and expression levels of cytokines from peritoneal macrophages were analyzed. RESULTS: Lgals9 deficiency protected against the development of immune complex glomerulonephritis, arthritis, and peritoneal lipogranuloma formation in BALB/c mice in this murine model of pristane-induced lupus. The populations of T cell subsets and B cells in the spleen and peritoneum were not altered by Lgals9 deficiency in pristane-injected BALB/c mice. Furthermore, Lgals9 deficiency protected against pristane-induced lupus without altering the Toll-like receptor 7-type I interferon pathway. CONCLUSION: Gal-9 is required for the induction and development of lupus nephritis and arthritis in this murine model of SLE. The results of the current investigation provide a potential new strategy in which antagonism of Gal-9 may be beneficial for the treatment of nephritis and arthritis in patients with SLE through targeting of activated macrophages.
引用
- Zeggar S, Watanabe KS, Teshigawara S, et al. Role of Lgals9 Deficiency in Attenuating Nephritis and Arthritis in BALB/c Mice in a Pristane-Induced Lupus Model. Arthritis Rheumatol. 2018. PMID: 29481735. doi:10.1002/art.40467
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。